London R E, Schmidt P G, Vavrek R J, Stewart J M
Int J Pept Protein Res. 1982 Apr;19(4):334-42.
Substitution of Pro residues with AIB (alpha-aminoisobutyric acid) residues in peptides provides a means of evaluating the presence of cis' proline conformations both in solution and, using bioassay data, in a receptor complex. 1H n.m.r. has been used to probe the DMSO solution conformation of all seven of the possible AIB/Pro isomers of bradykinin. AIB substitution for Pro2 and/or Pro3 appears to stabilize a type III beta-turn involving the N-terminal residues, but not an incipient 3(10) helix suggested by model peptides. These substitutions are correlated with low biological potencies, suggesting that such conformational features may be incompatible with receptor complexation. Alternatively, AIB7 -bradykinin analogs exhibit a variety of long range shift perturbations relative to bradykinin. The data suggests that bradykinin can adopt several folded conformations, including beta-turns involving both Ser6-Pro7-Phe8-Arg9 and Phe5-Ser6-Pro7-Phe8. The relatively high biological activities of the AIB7-BK suggest that the complexed form of the peptide is characterized by a cis' Pro7 conformation.
在肽中用α-氨基异丁酸(AIB)残基取代脯氨酸(Pro)残基,为评估溶液中以及利用生物测定数据在受体复合物中顺式脯氨酸构象的存在提供了一种方法。氢核磁共振(1H n.m.r.)已被用于探测缓激肽所有七种可能的AIB/Pro异构体在二甲基亚砜(DMSO)溶液中的构象。用AIB取代Pro2和/或Pro3似乎能稳定涉及N端残基的III型β-转角,但不能稳定模型肽所暗示的初始3(10)螺旋。这些取代与低生物活性相关,表明这种构象特征可能与受体复合不相容。另外,AIB7-缓激肽类似物相对于缓激肽表现出各种长程位移扰动。数据表明缓激肽可以采用几种折叠构象,包括涉及Ser6-Pro7-Phe8-Arg9和Phe5-Ser6-Pro7-Phe8的β-转角。AIB7-BK相对较高的生物活性表明该肽的复合形式以顺式Pro7构象为特征。